The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it strong buy, with a mean price target of $534. It reported earnings in this window, a natural checkpoint for the thesis.
S&P Global SPGI
Outside both standardsAn entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · S&P Global Inc., together with its subsidiaries, provides benchmarks, data, analytics, and workflow solutions in the global capital, energy and commodity, and automotive markets.
read at $426.40
S&P Global holds its Markup at $426.40.
- PHPhase · the trend structure carries the Markup label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · does not pass the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Markup |
| Quantitative state | The statistical read favours the buyers, held for 51 days |
| Price | $426.40 |
| Valuation | 27.00 trailing · 21.00 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 1.08 |
The opportunity · what the numbers say it is worth
Our framework reads AVOID — it trades above our $413.75 fair value estimate, moderate competitive moat, 10.40% revenue growth.
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Our more conservative model reads it as roughly fairly valued here, while the Street is more bullish — a quality-at-a-fair-price name rather than a deep-value one.
| Revenue growth | 10.40% |
| Profit margin | 30.36% |
| Debt to equity | 38.39 |
| Analyst consensus | Strong Buy · 18 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
This company is excluded by both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. It fails on both:
Used by most halal investing apps ✗ DOES NOT PASS
The one Titan applies ✗ DOES NOT PASS
Why it fails. The problem is its business activity screen. Because both standards agree on this, it is a clear exclusion, not a borderline case.
What these two standards are, and how they differ →
- Business activity Business activity: Financials sector Fail
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
Benchmarks everywhere yet still too dear
Every bond, loan and energy contract leans on S&P Global numbers to get priced and cleared. That reach keeps revenue growing at 10 percent and margins near 30 percent, yet the shares sit 8 percent above our fair value at a 22.2 times forward multiple. The market loves the franchise, but the price leaves no room for error.
We pass for two clear reasons. First, the valuation already bakes in perfection while return on equity sits at a modest 14 percent. Second, the business fails our ethical screen on activity grounds. Strong buy notes from eighteen analysts and a 523 dollar median target do not change those facts.
A moderate moat offers some protection, yet any slowdown in deal flow or regulatory pushback on ratings could compress multiples quickly. Analysis, not advice.
| Forward P/E | 21.0x expensive even after accounting for its growth |
| Trailing P/E | 27.0x a premium valuation |
| Revenue growth | 10.4% steady growth |
| Profit margin | 30.4% highly profitable on every dollar of sales |
| Return on equity | 13.9% a solid return on shareholder capital |
| Debt to equity | 0.38 minimal debt — a conservative balance sheet |
| Current ratio | 0.68 below 1 — short-term bills exceed liquid assets |
| Beta | 1.08 moves a little more than the market |
| Market cap | $126.2B |
| Employees | 44,500 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Latest news · what the market is reading on SPGI
- › Oracle Is Its Own Story, With Swings To Match Trefis · 2d ago
- › Tesla Stock Falls More Than Twice As Far As The Market In A Shock Trefis · 2d ago
- › Why IBM Stock May Be A Value Deal Trefis · 2d ago
- › AMC credit upgrade comes with a catch TheStreet · 3d ago
- › ACN Got Cheaper. The Business Did Not Get Worse Trefis · 3d ago
Headlines from third-party outlets, linked for reference — not our reporting, not advice.
Related securities · others in SPGI's space worth a look
Screened names in the same industry · explore each on its own page.
Where & how to trade · wherever in the world you are
SPGI trades on a US exchange. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it strong buy, with a mean price target of $534. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it strong buy, with a mean price target of $534. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it strong buy, with a mean price target of $534. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 5.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it strong buy, with a mean price target of $534. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it strong buy, with a mean price target of $534. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 6.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it strong buy, with a mean price target of $534. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (21 analysts) rates it strong buy, with a mean price target of $534.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
The insider ledger · Form 4 filings, as filed
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-01 | CLAY CATHERINE R | Officer | 2,500 | $1,078,475 | |
| 2026-04-30 | MORITZ ROBERT EDWARD JR. | Director | 1,151 | $500,001 | |
| 2026-04-29 | CHEUNG MARTINA | Chief Executive Officer | 2,322 | $998,297 | |
| 2026-04-01 | CRAIG CHRISTOPHER | Officer | 1,480 | $629,252 | |
| 2026-02-27 | ABOAF ERIC W | Chief Financial Officer | 1,091 | $482,091 | |
| 2026-02-24 | SAHA SAUGATA | Officer | 7,551 | · | |
| 2026-02-24 | MOORE SALLY ANN | Officer | 3,775 | · | |
| 2026-02-24 | GANESAN GIRISH | Officer | 1,226 | · | |
| 2026-02-24 | TWOMEY CHRISTINA | Officer | 546 | · | |
| 2026-02-24 | LE PALLEC YANN | Officer | 1,698 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
The political ledger · congressional disclosures
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-04-13 | Ro Khanna | Democrat | Sale | 1K–15K |
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $420.02 | +1.5% | $0.97 | $1,018 | +1.8% |
| 2 months | $414.46 | +2.9% | $0.97 | $1,031 | +3.1% |
| 3 months | $418.73 | +1.8% | $0.97 | $1,021 | +2.1% |
| 6 months | $495.25 | -13.9% | $1.94 | $865 | -13.5% |
| 1 year | $509.65 | -16.3% | $3.86 | $844 | -15.6% |
| 2 years | $423.35 | +0.7% | $7.60 | $1,025 | +2.5% |
| 3 years | $374.79 | +13.8% | $11.22 | $1,168 | +16.8% |
| 5 years | $376.40 | +13.3% | $17.88 | $1,180 | +18.0% |
Historical returns from market close data. Past performance does not guarantee future results.